Sweden · Delayed Price · Currency is SEK BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of SEK 30.32 billion. The enterprise value is 28.18 billion.
| Market Cap | 30.32B |
| Enterprise Value | 28.18B |
Important Dates
The next confirmed earnings date is Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
BioArctic AB has 88.72 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 74.32M |
| Shares Outstanding | 88.72M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 31.95% |
| Owned by Institutions (%) | 49.99% |
| Float | 54.61M |
Valuation Ratios
The trailing PE ratio is 29.67 and the forward PE ratio is 134.33. BioArctic AB's PEG ratio is 78.47.
| PE Ratio | 29.67 |
| Forward PE | 134.33 |
| PS Ratio | 15.17 |
| PB Ratio | 15.42 |
| P/TBV Ratio | 15.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 21.19 |
| PEG Ratio | 78.47 |
Enterprise Valuation
| EV / Earnings | 27.56 |
| EV / Sales | 14.10 |
| EV / EBITDA | n/a |
| EV / EBIT | 20.35 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.78 |
| Quick Ratio | 4.21 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 36.52 |
Financial Efficiency
Return on equity (ROE) is 71.44% and return on invested capital (ROIC) is 58.45%.
| Return on Equity (ROE) | 71.44% |
| Return on Assets (ROA) | 46.93% |
| Return on Invested Capital (ROIC) | 58.45% |
| Return on Capital Employed (ROCE) | 67.38% |
| Weighted Average Cost of Capital (WACC) | -0.02% |
| Revenue Per Employee | 15.26M |
| Profits Per Employee | 7.80M |
| Employee Count | 131 |
| Asset Turnover | 1.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioArctic AB has paid 233.26 million in taxes.
| Income Tax | 233.26M |
| Effective Tax Rate | 18.58% |
Stock Price Statistics
The stock price has increased by +103.04% in the last 52 weeks. The beta is -0.79, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.79 |
| 52-Week Price Change | +103.04% |
| 50-Day Moving Average | 318.04 |
| 200-Day Moving Average | 285.57 |
| Relative Strength Index (RSI) | 58.72 |
| Average Volume (20 Days) | 132,640 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of SEK 2.00 billion and earned 1.02 billion in profits. Earnings per share was 11.52.
| Revenue | 2.00B |
| Gross Profit | 1.94B |
| Operating Income | 1.38B |
| Pretax Income | 1.26B |
| Net Income | 1.02B |
| EBITDA | n/a |
| EBIT | 1.38B |
| Earnings Per Share (EPS) | 11.52 |
Balance Sheet
The company has 2.19 billion in cash and 44.07 million in debt, with a net cash position of 2.15 billion or 24.19 per share.
| Cash & Cash Equivalents | 2.19B |
| Total Debt | 44.07M |
| Net Cash | 2.15B |
| Net Cash Per Share | 24.19 |
| Equity (Book Value) | 1.97B |
| Book Value Per Share | 22.19 |
| Working Capital | 1.97B |
Cash Flow
| Operating Cash Flow | 1.43B |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 97.04%, with operating and profit margins of 69.25% and 51.14%.
| Gross Margin | 97.04% |
| Operating Margin | 69.25% |
| Pretax Margin | 62.81% |
| Profit Margin | 51.14% |
| EBITDA Margin | n/a |
| EBIT Margin | 69.25% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.60%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.60% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.25% |
| Shareholder Yield | 0.36% |
| Earnings Yield | 3.37% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |